Status:
COMPLETED
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)
Lead Sponsor:
Organon and Co
Conditions:
Respiratory Syncytial Virus Bronchiolitis
Eligibility:
All Genders
18-6 years
Brief Summary
This is a prospective, multicenter, observational study in participants who completed the 24-week, placebo-controlled MK-0476 Protocol 272 (NCT00076973) study of montelukast in the treatment of respir...
Eligibility Criteria
Inclusion
- successfully completed MK-0476 Protocol 272
- had RSV-induced bronchiolitis at entry into Protocol 272
Exclusion
- had developed or had been diagnosed with any illness or congenital disorder that could be immediately life threatening
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
343 Patients enrolled
Trial Details
Trial ID
NCT01140048
Start Date
October 1 2007
End Date
October 1 2011
Last Update
February 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.